Cargando…
A Review of the Therapeutic Targeting of SCN9A and Nav1.7 for Pain Relief in Current Human Clinical Trials
INTRODUCTION: There is a great need to find alternative treatments for chronic pain which have become a healthcare problem. We discuss current therapeutic targeting Nav1.7. AREAS COVERED: Nav1.7 is a sodium ion channel protein that is associated with several human pain genetic syndromes. It has been...
Autores principales: | Dormer, Anton, Narayanan, Mahesh, Schentag, Jerome, Achinko, Daniel, Norman, Elton, Kerrigan, James, Jay, Gary, Heydorn, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166096/ https://www.ncbi.nlm.nih.gov/pubmed/37168847 http://dx.doi.org/10.2147/JPR.S388896 |
Ejemplares similares
-
Targeted immune epitope prediction to HHLA2 and MAGEB5 protein variants as therapeutic approach to related viral diseases
por: Achinko, Daniel A., et al.
Publicado: (2021) -
Sporadic Erythromelalgia Associated with a Homozygous Carrier of Common Missense Polymorphism in SCN9A Gene Coding for NaV1.7 Voltage-gated Sodium Channel
por: Janicki, Piotr K, et al.
Publicado: (2019) -
Contrasting Nav1.8 Activity in Scn10a
(−/−) Ventricular Myocytes and the Intact Heart
por: Stroud, Dina Myers, et al.
Publicado: (2016) -
Electroacupuncture Reduces Carrageenan- and CFA-Induced Inflammatory Pain Accompanied by Changing the Expression of Nav1.7 and Nav1.8, rather than Nav1.9, in Mice Dorsal Root Ganglia
por: Huang, Chun-Ping, et al.
Publicado: (2013) -
Animal Toxins Can Alter the Function of Nav1.8 and Nav1.9
por: Gilchrist, John, et al.
Publicado: (2012)